SU1138164A1
(en)
|
1963-04-25 |
1985-02-07 |
Shadurskij Konstantin S |
Antihistamine agent "dimebon"
|
US4407957A
(en)
|
1981-03-13 |
1983-10-04 |
Damon Corporation |
Reversible microencapsulation of a core material
|
FI844786A0
(en)
|
1984-12-04 |
1984-12-04 |
Farmos Oy |
TERAPEUTISKT UTNYTTJBAR FOERENING.
|
US4839170A
(en)
|
1985-10-01 |
1989-06-13 |
Survival Technology, Inc. |
Protein absorption enhancing agents
|
US4767789A
(en)
|
1986-10-21 |
1988-08-30 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
US4760094A
(en)
|
1986-10-21 |
1988-07-26 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
US4760093A
(en)
|
1986-10-21 |
1988-07-26 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
US5039540A
(en)
|
1989-08-14 |
1991-08-13 |
Neophore Technologies, Inc. |
Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
|
US5217718A
(en)
|
1989-08-18 |
1993-06-08 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
US5178878A
(en)
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
US5215756A
(en)
|
1989-12-22 |
1993-06-01 |
Gole Dilip J |
Preparation of pharmaceutical and other matrix systems by solid-state dissolution
|
US5188825A
(en)
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
JP4215273B2
(en)
|
1991-04-25 |
2009-01-28 |
ブラウン ユニヴァーシティ リサーチ ファンデーション |
Implantable and biocompatible immunoblocking vehicle for the release of selected therapeutic agents
|
US5352456A
(en)
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
CA2145418A1
(en)
|
1992-09-29 |
1994-04-14 |
John S. Patton |
Pulmonary delivery of active fragments of parathyroid hormone
|
US5343672A
(en)
|
1992-12-01 |
1994-09-06 |
Scherer Ltd R P |
Method for manufacturing freeze dried dosages in a multilaminate blister pack
|
EP0804170B1
(en)
|
1993-07-09 |
2001-11-14 |
R.P. Scherer Corporation |
Method for making freeze dried drug dosage forms
|
GB2281206A
(en)
|
1993-08-25 |
1995-03-01 |
Orion Yhtymae Oy |
Use of dexmedetomidine
|
US5457895A
(en)
|
1993-10-01 |
1995-10-17 |
R. P. Scherer Corporation |
Method of identifying freeze-dried dosage forms
|
US5508367A
(en)
|
1993-11-29 |
1996-04-16 |
Adhesives Research, Inc. |
Water-soluble pressure sensitive adhesive
|
WO1995014746A2
(en)
|
1993-11-29 |
1995-06-01 |
Adhesives Research, Inc. |
Water-soluble pressure sensitive adhesive
|
US5395907A
(en)
|
1993-11-29 |
1995-03-07 |
Adhesive Research, Inc. |
Water-soluble pressure sensitive adhesive
|
FR2718357B1
(en)
|
1994-04-06 |
1997-10-03 |
Defarges Alain Moreau |
Improvements made to a needleless jet injection device.
|
GB2290964A
(en)
|
1994-07-08 |
1996-01-17 |
Arto Olavi Urtti |
Transdermal drug delivery system
|
US5731387A
(en)
|
1994-07-11 |
1998-03-24 |
Adhesives Research, Inc. |
Ionically-crosslinked water-absorbent graft copolymer
|
US5726250A
(en)
|
1994-07-11 |
1998-03-10 |
Adhesives Research, Inc. |
Covalently crosslinked water-absorbent graft copolymer
|
US5837287A
(en)
|
1994-10-28 |
1998-11-17 |
R P Scherer Corporation |
Process for preparing solid pharmaceutical dosage forms
|
US6726928B2
(en)
|
1994-10-28 |
2004-04-27 |
R.P. Scherer Technologies, Inc. |
Process for preparing solid dosage forms for unpalatable pharmaceuticals
|
GB9421836D0
(en)
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
US5605911A
(en)
|
1995-01-31 |
1997-02-25 |
Washington University |
Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)
|
US5700873A
(en)
|
1995-03-07 |
1997-12-23 |
Adhesives Research, Inc. |
Method of preparation of water-soluble copolymer
|
US5780014A
(en)
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5654007A
(en)
|
1995-06-07 |
1997-08-05 |
Inhale Therapeutic Systems |
Methods and system for processing dispersible fine powders
|
GB9616672D0
(en)
|
1996-08-08 |
1996-09-25 |
Scherer Ltd R P |
Pharmaceutical compositions
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
GB9702799D0
(en)
|
1997-02-12 |
1997-04-02 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms
|
EP0973507B1
(en)
|
1997-02-20 |
2009-01-21 |
Massachussets Institute of Technology |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
CA2276339A1
(en)
|
1997-02-21 |
1998-08-27 |
Michael J. Zajaczkowski |
Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
|
US5951999A
(en)
|
1997-02-21 |
1999-09-14 |
Adhesives Research, Inc. |
Transdermal pressure sensitive adhesive drug delivery system
|
US6239228B1
(en)
|
1997-02-21 |
2001-05-29 |
Adhesives Research, Inc. |
Pressure sensitive adhesive containing macromer having repeat hydrophilic moieties
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
US5976577A
(en)
|
1997-07-11 |
1999-11-02 |
Rp Scherer Corporation |
Process for preparing fast dispersing solid oral dosage form
|
ATE323467T1
(en)
|
1997-07-25 |
2006-05-15 |
Alpex Pharma Sa |
METHOD FOR PRODUCING A GRANULE SUITABLE FOR PRODUCING RAPID-RELEASE, MOUTH-SOLUBLE TABLETS
|
US7632517B2
(en)
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
GB9802088D0
(en)
|
1998-01-30 |
1998-03-25 |
Scherer Ltd R P |
Pharmaceutical products
|
WO1999046168A1
(en)
|
1998-03-09 |
1999-09-16 |
Cima Labs Inc. |
Apparatus for handling and packaging friable tablets
|
US6200604B1
(en)
|
1998-03-27 |
2001-03-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6716867B1
(en)
|
1998-04-01 |
2004-04-06 |
Orion Corporation |
Use of dexmedetomidine for ICU sedation
|
US7565905B2
(en)
|
1998-06-03 |
2009-07-28 |
Scott Laboratories, Inc. |
Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness
|
AU2005201500B2
(en)
|
1998-06-03 |
2007-01-04 |
Scott Laboratories, Inc. |
Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
|
EP1082056B1
(en)
|
1998-06-03 |
2007-11-14 |
Scott Laboratories, Inc. |
Apparatus for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
PL201578B1
(en)
|
1998-11-20 |
2009-04-30 |
Skyepharma Canada Inc |
Dispersible phospholipid stabilized microparticles
|
GB9901819D0
(en)
|
1999-01-27 |
1999-03-17 |
Scherer Corp R P |
Pharmaceutical compositions
|
GB9908014D0
(en)
|
1999-04-08 |
1999-06-02 |
Scherer Corp R P |
Pharmaceutical compositions
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
DE19940740A1
(en)
|
1999-08-31 |
2001-03-01 |
Gruenenthal Gmbh |
Pharmaceutical salts
|
US6984207B1
(en)
|
1999-09-14 |
2006-01-10 |
Hoana Medical, Inc. |
Passive physiological monitoring (P2M) system
|
CA2324967A1
(en)
|
2000-11-01 |
2002-05-01 |
3816133 Canada Inc. |
System for monitoring patients with alzheimer's disease or related dementia
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
AU7323001A
(en)
*
|
2000-07-07 |
2002-01-21 |
Av Topchiev Inst Petrochemical |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US20020192287A1
(en)
|
2000-11-09 |
2002-12-19 |
Mooney Mark T. |
Extrudable compositions for topical or transdermal drug delivery
|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US6814978B2
(en)
|
2000-12-29 |
2004-11-09 |
Mcneil-Ppc, Inc. |
Process for preparing a soft tablet
|
US20030022926A1
(en)
|
2001-05-07 |
2003-01-30 |
Lavand'homme Patricia |
Method for treating neuropathic pain and pharmaceutical preparation therefor
|
EP2246799A1
(en)
|
2001-05-15 |
2010-11-03 |
Psychogenics Inc. |
Systems and methods for monitoring behaviour informatics
|
US6509040B1
(en)
|
2001-06-22 |
2003-01-21 |
R.P. Scherer Corporation |
Fast dispersing dosage forms essentially free of mammalian gelatin
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US20140271788A1
(en)
|
2013-03-15 |
2014-09-18 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20070281003A1
(en)
*
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US7425292B2
(en)
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
EP1443912B1
(en)
|
2001-10-12 |
2007-08-29 |
Elan Pharma International Limited |
Compositions having a combination of immediate release and controlled release characteristics
|
FR2832311B1
(en)
|
2001-11-21 |
2004-04-16 |
Besins Int Belgique |
FILM-FORMING POWDER, COMPOSITIONS COMPRISING SAME, PREPARATION METHODS AND USES THEREOF
|
FR2834212B1
(en)
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
USE OF IMMEDIATE RELEASE POWDER IN PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
|
WO2003068604A1
(en)
|
2002-02-13 |
2003-08-21 |
Weibel Michael K |
Drug dose-form and method of manufacture
|
DE60327335D1
(en)
|
2002-10-08 |
2009-06-04 |
Allergan Inc |
ALPHA 2B OR 2B / 2C ADRENOZEPTOR AGONISTS FOR THE TREATMENT OF MORBUS ALZHEIMER AND MORBUS PARKINSON
|
US20040156894A1
(en)
|
2003-02-07 |
2004-08-12 |
Grother Leon Paul |
Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
|
AU2004319243B2
(en)
|
2003-05-28 |
2010-06-03 |
Aquestive Therapeutics, Inc. |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US7282217B1
(en)
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
US9248146B2
(en)
|
2003-10-24 |
2016-02-02 |
Adhesives Research, Inc. |
Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
|
US20050118217A1
(en)
|
2003-10-24 |
2005-06-02 |
Barnhart Scott D. |
Rapidly disintegrating films for delivery of pharmaceutical of cosmetic agents
|
GB0403808D0
(en)
*
|
2004-02-20 |
2004-03-24 |
Bioprogress Technology Ltd |
Films for use as dosage forms
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
US7972621B2
(en)
|
2004-06-03 |
2011-07-05 |
R.P. Scherer Technologies, Llc |
Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
|
US20060058590A1
(en)
|
2004-08-24 |
2006-03-16 |
Shaw Geoffrey M |
Method and system for assaying agitation
|
US20060058700A1
(en)
|
2004-08-26 |
2006-03-16 |
Marro Dominic P |
Patient sedation monitor
|
CN101065014A
(en)
|
2004-09-23 |
2007-10-31 |
亚历山大·米哈洛 |
Methods for regulating neurotransmitter systems by inducing counteradaptations
|
CA2599148A1
(en)
|
2005-02-22 |
2006-08-31 |
Health-Smart Limited |
Methods and systems for physiological and psycho-physiological monitoring and uses thereof
|
US20060199805A1
(en)
|
2005-03-04 |
2006-09-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
|
WO2007010242A1
(en)
|
2005-07-18 |
2007-01-25 |
Imperial College Innovations Limited |
Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders
|
US20070106126A1
(en)
|
2005-09-30 |
2007-05-10 |
Mannheimer Paul D |
Patient monitoring alarm escalation system and method
|
US20070117835A1
(en)
|
2005-10-04 |
2007-05-24 |
David Hung |
Methods and compositions for treating Huntington's disease
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
JP2009521523A
(en)
|
2005-12-27 |
2009-06-04 |
ジュビラント・オルガノシス・リミテッド |
Mouth-soluble pharmaceutical composition and method for producing the same
|
US8481583B2
(en)
|
2006-02-13 |
2013-07-09 |
Orient Pharma (Samoa) Co., Ltd. |
Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
|
US7630758B2
(en)
|
2006-06-22 |
2009-12-08 |
General Electric Company |
Separation of natural and drug-induced sleep of a subject
|
US20080026040A1
(en)
*
|
2006-07-31 |
2008-01-31 |
Isaac Farr |
Active agent-releasing dosage forms
|
AU2007297697A1
(en)
|
2006-09-20 |
2008-03-27 |
Monosol Rx Llc |
Edible water-soluble film containing a foam reducing flavoring agent
|
US8157730B2
(en)
|
2006-12-19 |
2012-04-17 |
Valencell, Inc. |
Physiological and environmental monitoring systems and methods
|
US20080153808A1
(en)
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Alpha-2 receptor pan agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain
|
WO2008091588A1
(en)
|
2007-01-22 |
2008-07-31 |
Targacept, Inc. |
Intranasal, buccal, and sublingual administration of metanicotine analogs
|
US8568777B2
(en)
|
2007-03-30 |
2013-10-29 |
Monosol Rx, Llc |
Packaged film dosage unit containing a complexate
|
BRPI0811430A2
(en)
|
2007-05-10 |
2015-06-23 |
Novadel Pharma Inc |
Anti-Insomnia Compositions and Processes
|
US20090099480A1
(en)
|
2007-05-24 |
2009-04-16 |
Peter Salgo |
System and method for patient monitoring
|
CN101686942B
(en)
|
2007-06-27 |
2012-09-26 |
韩美药品株式会社 |
Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
|
RU2338533C1
(en)
|
2007-06-28 |
2008-11-20 |
Сергей Олегович Бачурин |
AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION
|
MX2010001218A
(en)
|
2007-08-01 |
2010-04-07 |
Medivation Neurology Inc |
Methods and compositions for treating schizophrenia using antipsychotic combination therapy.
|
CN101877975A
(en)
|
2007-10-11 |
2010-11-03 |
菲利普莫里斯生产公司 |
Smokeless tobacco product
|
US8298583B2
(en)
|
2007-10-19 |
2012-10-30 |
Monosol Rx, Llc |
Film delivery system for tetrahydrolipstatin
|
PE20091084A1
(en)
|
2007-12-07 |
2009-07-23 |
Schering Plough Healthcare |
PHARMACEUTICAL FORMULATIONS OF PHENYLPHRINE AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION
|
CN101496801A
(en)
|
2008-02-02 |
2009-08-05 |
四川百利药业有限责任公司 |
Dexmedetomidine and use of pharmaceutical salt thereof
|
US20100285134A1
(en)
|
2008-02-15 |
2010-11-11 |
Bone Therepeutics |
Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
|
MY173867A
(en)
|
2008-02-28 |
2020-02-25 |
Scherer Technologies Llc R P |
Process to minimize polymorphism
|
US20190216389A1
(en)
|
2008-04-07 |
2019-07-18 |
Christopher Scheib |
Method and system for analyzing a series of electroencephalogram (eeg) signals during altered brain states
|
US20090275853A1
(en)
|
2008-04-30 |
2009-11-05 |
The General Electric Company |
Method and apparatus for monitoring physiological state of a subject
|
US8882684B2
(en)
|
2008-05-12 |
2014-11-11 |
Earlysense Ltd. |
Monitoring, predicting and treating clinical episodes
|
WO2010014758A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Pharmaceuticals, Inc. |
Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
|
US20110172262A1
(en)
|
2008-09-15 |
2011-07-14 |
Biovista, Inc. |
Compositions and methods for treating epilepsy
|
US8613937B2
(en)
|
2008-10-31 |
2013-12-24 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US8518031B2
(en)
|
2008-10-31 |
2013-08-27 |
The Invention Science Fund I, Llc |
Systems, devices and methods for making or administering frozen particles
|
US8470546B2
(en)
|
2008-11-25 |
2013-06-25 |
Albert Einstein College Of Medicine Of Yeshiva University |
Treatment of autism spectrum disorders with agents that activate the Locus Coeruleus-Noradrenergic system
|
WO2010065547A1
(en)
|
2008-12-01 |
2010-06-10 |
Map Pharmaceuticals, Inc. |
Inhalation delivery methods and devices
|
US8282954B2
(en)
|
2008-12-15 |
2012-10-09 |
Monosol Rx, Llc |
Method for manufacturing edible film
|
TR200903014A1
(en)
|
2009-04-17 |
2010-11-22 |
Sanovel İlaç San. Ve Ti̇c. A.Ş. |
Orally dispersed dimebolin compounds.
|
RU2572692C2
(en)
|
2009-05-15 |
2016-01-20 |
Рекро Фарма, Инк. |
Dexmedetomidine sublingual compositions and methods of application thereof
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
US9775819B2
(en)
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
WO2011039686A1
(en)
|
2009-09-30 |
2011-04-07 |
Pfizer Inc. |
Latrepirdine oral sustained release dosage forms
|
NZ601195A
(en)
|
2010-01-08 |
2015-02-27 |
Recro Pharma Inc |
Topical transdermal dexmedetomidine compositions and methods of use thereof
|
WO2011109716A2
(en)
|
2010-03-04 |
2011-09-09 |
Neumitra LLC |
Devices and methods for treating psychological disorders
|
US10548839B2
(en)
|
2010-03-16 |
2020-02-04 |
Wei Tian |
Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
|
EP2558101A4
(en)
|
2010-04-15 |
2013-09-18 |
Univ Mcgill |
Topical treatments for pain
|
US9572773B2
(en)
|
2010-04-26 |
2017-02-21 |
Novartis A.G. |
Layered drug delivery device
|
US20110290694A1
(en)
|
2010-05-27 |
2011-12-01 |
Monosol Rx, Llc |
Oral film dosage form having indicia thereon
|
US8529914B2
(en)
|
2010-06-28 |
2013-09-10 |
Richard C. Fuisz |
Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
|
EP2605698B1
(en)
|
2010-08-17 |
2020-04-15 |
University of Florida Research Foundation, Inc. |
Central site photoplethysmography, medication administration, and safety
|
KR101802553B1
(en)
|
2010-09-23 |
2017-11-28 |
모노졸 알엑스, 엘엘씨 |
Method and system for forming a pharmaceutical product directly onto a packaging surface
|
US8383135B2
(en)
|
2010-12-03 |
2013-02-26 |
Richard C. Fuisz |
Solid dosage form that promotes reliable oral, esophageal and GI transit
|
HUE049349T2
(en)
|
2010-12-16 |
2020-09-28 |
Sunovion Pharmaceuticals Inc |
Sublingual films
|
US10130684B2
(en)
*
|
2011-02-03 |
2018-11-20 |
Pharmedica Ltd. |
Oral dissolving films for insulin administration, for treating diabetes
|
US8445526B2
(en)
|
2011-02-03 |
2013-05-21 |
Glaucoma & Nasal Therapies Llc |
Compositions and methods for treatment of glaucoma
|
US20140163080A1
(en)
|
2011-02-03 |
2014-06-12 |
Gnt, Llc |
Compositions and Methods for Treatment of Glaucoma
|
US8703697B2
(en)
|
2011-06-24 |
2014-04-22 |
Luc QUINTIN |
Method for treating early severe diffuse acute respiratory distress syndrome
|
US8241661B1
(en)
|
2011-06-24 |
2012-08-14 |
Fuisz Richard C |
Biocompatible film with variable cross-sectional properties
|
US20130096170A1
(en)
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
US20130116215A1
(en)
|
2011-10-28 |
2013-05-09 |
Mireia Coma |
Combination therapies for treating neurological disorders
|
BR112014019171A8
(en)
|
2011-12-11 |
2017-07-11 |
Recro Pharma Inc |
DEXDETOMIDE INTRANASAL COMPOSITIONS AND THEIR METHODS OF USE
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
JP2015517980A
(en)
|
2012-02-27 |
2015-06-25 |
アイ・セラピーズ・エル・エル・シー |
Compositions and methods for the treatment of migraine
|
JP5921928B2
(en)
|
2012-03-28 |
2016-05-24 |
テルモ株式会社 |
Already diluted dexmedetomidine preparation
|
CN102657635B
(en)
*
|
2012-05-04 |
2013-08-07 |
上海现代药物制剂工程研究中心有限公司 |
Spongy asenapine sublingual film agent with micropores and preparation method thereof
|
WO2013173317A1
(en)
|
2012-05-14 |
2013-11-21 |
Prospire, Llc |
TREATMENT OF OBSTRUCTIVE SLEEP APNEA WITH α2-ADRENERGIC RECEPTOR AGONISTS
|
BR112015000150A2
(en)
|
2012-07-06 |
2017-06-27 |
Egalet Ltd |
controlled release abuse deterrent pharmaceutical compositions
|
US10130766B1
(en)
|
2012-08-08 |
2018-11-20 |
Neurowave Systems Inc. |
Intelligent pharmaceutical delivery system with automatic shutoff and method of using
|
US20140180160A1
(en)
|
2012-10-12 |
2014-06-26 |
Emery N. Brown |
System and method for monitoring and controlling a state of a patient during and after administration of anesthetic compound
|
SI2719376T1
(en)
|
2012-10-12 |
2015-06-30 |
Omya International Ag |
Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
|
DK2906213T3
(en)
|
2012-10-15 |
2018-02-19 |
Orion Corp |
VETERINARY PROCEDURE FOR RELIEFING NOISE SENSITIVITY
|
GB2510321B
(en)
|
2012-11-12 |
2018-01-31 |
Biosurgical S L |
Agitation apparatus
|
US9545376B2
(en)
|
2013-01-23 |
2017-01-17 |
Arx, Llc |
Production of unit dose constructs
|
WO2014130777A1
(en)
|
2013-02-21 |
2014-08-28 |
University Of Rochester |
Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon
|
US9346601B2
(en)
|
2013-03-15 |
2016-05-24 |
Monosol Rx, Llc |
Reduction in stress cracking of films
|
US20140261990A1
(en)
|
2013-03-15 |
2014-09-18 |
Monosol Rx, Llc |
Multi-layer films having uniform content
|
US9303918B2
(en)
|
2013-03-15 |
2016-04-05 |
Monosol Rx, Llc |
Process for drying a wet film with control of loss on drying
|
US20140328898A1
(en)
|
2013-03-15 |
2014-11-06 |
Children's National Medical Center |
Nano-Liposomal Formulations and Methods of Use
|
SG11201507898UA
(en)
|
2013-03-22 |
2015-11-27 |
Adhesives Res Inc |
Hydrophilic adhesives and tapes and devices containing the same
|
US20140316217A1
(en)
|
2013-04-23 |
2014-10-23 |
Patrick L. Purdon |
System and method for monitoring anesthesia and sedation using measures of brain coherence and synchrony
|
WO2014176436A1
(en)
|
2013-04-24 |
2014-10-30 |
The General Hospital Corporation |
System and method for estimating high time-frequency resolution eeg spectrograms to monitor patient state
|
US20140323898A1
(en)
|
2013-04-24 |
2014-10-30 |
Patrick L. Purdon |
System and Method for Monitoring Level of Dexmedatomidine-Induced Sedation
|
CN103284945A
(en)
|
2013-06-03 |
2013-09-11 |
四川百利药业有限责任公司 |
Preparation method of pre-filled dexmedetomidine hydrochloride injection
|
US9073294B2
(en)
|
2013-06-04 |
2015-07-07 |
Monosol, Llc |
Method for sealing a water-soluble film by applying a sealing solution
|
WO2014210549A1
(en)
|
2013-06-27 |
2014-12-31 |
The General Hospital Corporation |
Systems and methods for tracking non-stationary spectral structure and dynamics in physiological data
|
WO2014210527A1
(en)
|
2013-06-28 |
2014-12-31 |
The General Hospital Corporation |
System and method to infer brain state during burst suppression
|
US10602978B2
(en)
|
2013-09-13 |
2020-03-31 |
The General Hospital Corporation |
Systems and methods for improved brain monitoring during general anesthesia and sedation
|
KR101881791B1
(en)
|
2013-10-07 |
2018-07-25 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
|
RU2658463C2
(en)
|
2013-10-07 |
2018-06-21 |
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. |
Attention deficit hyperactivity disorder, anxiety and insomnia treatment methods and compositions with application of the dexmedetomidine based transdermal compositions
|
ES2855103T3
(en)
|
2013-10-07 |
2021-09-23 |
Teikoku Pharma Usa Inc |
Transdermal delivery device for pain control comprising transdermal compositions of dexmedetomidine
|
JP6188933B2
(en)
|
2013-10-07 |
2017-08-30 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
Methods and compositions for transdermal delivery of non-sedating amounts of dexmedetomidine
|
CN105764494A
(en)
|
2013-10-07 |
2016-07-13 |
帝国制药美国公司 |
Dexmedetomidine Transdermal Delivery Devices and Methods for Using the Same
|
WO2015069778A1
(en)
|
2013-11-05 |
2015-05-14 |
The General Hospital Corporation |
System and method for determining neural states from physiological measurements
|
US11033493B2
(en)
|
2013-12-02 |
2021-06-15 |
Intelgenx Corp. |
Film dosage form with extended release mucoadhesive particles
|
WO2015093503A1
(en)
|
2013-12-18 |
2015-06-25 |
丸石製薬株式会社 |
Water-containing adhesive patch
|
US20170274174A1
(en)
|
2014-08-22 |
2017-09-28 |
The General Hospital Corporation |
System and method for administering, monitoring and controlling biomimetic sleep
|
WO2016029211A1
(en)
|
2014-08-22 |
2016-02-25 |
The General Hospital Corporation |
Systems and methods for discovery and characterization of neuroactive drugs
|
US20170231556A1
(en)
|
2014-08-22 |
2017-08-17 |
The General Hospital Corporation |
Systems and methods for predicting arousal to consciousness during general anesthesia and sedation
|
CN104161760A
(en)
|
2014-09-01 |
2014-11-26 |
西北农林科技大学 |
Compound anesthetic for racoon dogs as well as preparation method and application thereof
|
MA41689A
(en)
|
2014-10-15 |
2017-08-22 |
Bioxcel Corp |
PREVENTION OR TREATMENT OF SLEEP DISORDERS WITH A DEXMEDETOMIDINE FORMULATION
|
WO2016061554A1
(en)
|
2014-10-16 |
2016-04-21 |
Bioxcel Corporation |
Synergistic composition of known, safe pharmaceuticals for use in insomnia and a method of treatment thereof
|
FI127534B
(en)
|
2014-11-10 |
2018-08-31 |
Vetcare Oy |
COMPOSITIONS COMPRISING SUBSTITUTED BENZOFUROQUINOLIZINE AND ɑ2-ADRENERGIC AGONISTS
|
US10022341B2
(en)
|
2014-12-02 |
2018-07-17 |
Yale University |
Methods of preventing neurodegeneration of association cortex in a mammal
|
JP2016154598A
(en)
|
2015-02-23 |
2016-09-01 |
ニプロ株式会社 |
Prefilled syringe filled with dexmedetomidine injection solution
|
CN104784174A
(en)
|
2015-03-06 |
2015-07-22 |
北京大学第一医院 |
New pharmaceutical use of dexmedetomidine
|
CN107683140A
(en)
|
2015-04-10 |
2018-02-09 |
特丽珂生物医学股份有限公司 |
For controlling bleeding and the bioadhesive chitosan gel for promoting to cure, it reduces scar without fuzzy or interference visual area acquisition
|
CN106038538A
(en)
|
2015-04-17 |
2016-10-26 |
江苏恒瑞医药股份有限公司 |
Premixed preparation for dexmedetomidine
|
US10179136B2
(en)
|
2015-06-19 |
2019-01-15 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for anesthesiological applications
|
US20160374588A1
(en)
|
2015-06-24 |
2016-12-29 |
Microsoft Technology Licensing, Llc |
Monitoring hydration based on galvanic skin response
|
CN105168122B
(en)
|
2015-09-24 |
2018-11-27 |
辰欣药业股份有限公司 |
A kind of dexmedetomidine hydrochloride injection and its preparation process
|
US20170128421A1
(en)
|
2015-11-11 |
2017-05-11 |
Siva Prasad Reddy Sura |
Premix formulation for parenteral use and packaging thereof
|
US10632043B2
(en)
|
2015-11-11 |
2020-04-28 |
Aurobindo Pharma Ltd |
Premix formulation for parenteral use and packaging thereof
|
CA3009697A1
(en)
|
2016-01-04 |
2017-07-13 |
Jurox Pty Ltd |
Drug release device and use
|
CN105534891A
(en)
|
2016-01-18 |
2016-05-04 |
南京正科医药股份有限公司 |
Dexmedetomidine hydrochloride injection
|
US9949934B1
(en)
|
2016-10-20 |
2018-04-24 |
Intelgenx Corp. |
Device and method of treating conditions associated with neuroinflammation
|
US9717796B1
(en)
|
2016-04-20 |
2017-08-01 |
Slypharma, Llc |
Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
|
CN107412152B
(en)
|
2016-05-24 |
2020-12-04 |
海南合瑞制药股份有限公司 |
Dexmedetomidine hydrochloride injection composition
|
CA3026783A1
(en)
|
2016-06-07 |
2017-12-14 |
Akhil MEHRA |
Methods and compositions for the treatment of trauma and stressor-related disorders
|
CN105997955B
(en)
|
2016-06-28 |
2017-09-12 |
力品药业(厦门)有限公司 |
A kind of Palonosetron oral cavity membrane and preparation method thereof
|
RU2635532C1
(en)
|
2016-09-06 |
2017-11-13 |
Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации |
Method for prevention of agitation syndrome in children with oncological pathology
|
CA3039464A1
(en)
*
|
2016-10-12 |
2018-04-19 |
Ps Therapy Ltd. |
Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
|
CA3040422A1
(en)
|
2016-10-13 |
2018-04-19 |
Catalent U.K. Swindon Zydis Limited |
Lyophilized pharmaceutical compositions for vaginal delivery
|
WO2018078548A1
(en)
|
2016-10-25 |
2018-05-03 |
Catalent U.K. Swindon Zydis Limited |
Compositions of different densities for fast disintegrating multi-layer tablet
|
CN110022865A
(en)
|
2016-10-31 |
2019-07-16 |
帝国制药美国公司 |
Use the method for Dexmedetomidine transdermal delivery device management pain
|
US20180147201A1
(en)
|
2016-10-31 |
2018-05-31 |
Allodynic Therapeutics, Llc |
Combinations of opioid/tlr4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia
|
CN106727524A
(en)
|
2016-11-08 |
2017-05-31 |
叶茂 |
A kind of pharmaceutical composition and its application
|
CN106539778A
(en)
|
2016-12-08 |
2017-03-29 |
武汉大学 |
Preoperative buccal oral cavity effervescent tablet of a kind of pediatric anesthesia and preparation method thereof
|
CN106727443A
(en)
|
2016-12-08 |
2017-05-31 |
武汉大学 |
Preoperative calm stealthy nose paste preparation of a kind of pediatric anesthesia and preparation method thereof
|
CA3046286A1
(en)
|
2016-12-13 |
2018-06-21 |
Orion Corporation |
Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs
|
WO2018116202A1
(en)
|
2016-12-20 |
2018-06-28 |
Azista Industries Pvt Ltd |
Stabilized mouth freshener strips
|
MX2019007923A
(en)
|
2016-12-31 |
2019-09-10 |
Bioxcel Therapeutics Inc |
Use of sublingual dexmedetomidine for the treatment of agitation.
|
US11554106B2
(en)
|
2017-03-07 |
2023-01-17 |
Marc Childs |
Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin
|
CN107137399A
(en)
|
2017-04-24 |
2017-09-08 |
徐颖 |
A kind of sublingual tablet for being used to anaesthetize and preparation method thereof
|
CN107693485A
(en)
|
2017-04-24 |
2018-02-16 |
重庆医科大学附属儿童医院 |
A kind of nasal drops for being used to anaesthetize and preparation method thereof
|
CN107412204A
(en)
|
2017-04-24 |
2017-12-01 |
重庆医科大学附属儿童医院 |
A kind of Foradil Aerolizer formoterol fumarate for being used to anaesthetize and preparation method thereof
|
CN107028880A
(en)
|
2017-06-09 |
2017-08-11 |
安徽赛诺制药有限公司 |
A kind of production technology of dexmedetomidine hydrochloride parenteral solution
|
EP3668488A4
(en)
|
2017-08-15 |
2021-03-24 |
The Board of Trustees of the Leland Stanford Junior University |
Polymeric perfluorocarbon nanoemulsions for ultrasonic drug uncaging
|
CA3071552A1
(en)
|
2017-08-20 |
2019-02-28 |
Formulex Pharma Innovations Ltd. |
Dry powder compositions for intranasal delivery
|
US11857334B2
(en)
|
2017-10-04 |
2024-01-02 |
The General Hospital Corporation |
Systems and methods for monitoring a subject under the influence of drugs
|
US20190216345A1
(en)
|
2017-10-18 |
2019-07-18 |
Christoper Scheib |
Method and system for monitoring and displaying physiological conditions
|
US11147459B2
(en)
|
2018-01-05 |
2021-10-19 |
CareBand Inc. |
Wearable electronic device and system for tracking location and identifying changes in salient indicators of patient health
|
US11406316B2
(en)
|
2018-02-14 |
2022-08-09 |
Cerenion Oy |
Apparatus and method for electroencephalographic measurement
|
WO2019171173A1
(en)
|
2018-03-08 |
2019-09-12 |
Catalent U.K. Swindon Zydis Limited |
Process to reduce endotoxin in gelatin
|
KR20190109310A
(en)
|
2018-03-15 |
2019-09-25 |
주식회사 바이오홀딩스 |
Nasal spray type formuation comprising levan for treating inflamentory diseases
|
CN108498469A
(en)
|
2018-05-30 |
2018-09-07 |
宁波蒙曼生物科技有限公司 |
Dexmedetomidine hydrochloride freeze-dried powder and preparation method thereof
|
CN114983979A
(en)
|
2018-06-27 |
2022-09-02 |
比奥克斯塞尔医疗股份有限公司 |
Dexmedetomidine-containing film preparation and method for producing the same
|
WO2020006119A1
(en)
|
2018-06-27 |
2020-01-02 |
Bioxcel Therapeutics, Inc. |
Methods for treating agitation using dexmedetomidine hydrochloride
|
JP7365409B2
(en)
|
2018-06-28 |
2023-10-19 |
エイアールエックス エルエルシー |
Dispensing method for producing soluble unit dose membrane constructs
|
CN110893186A
(en)
|
2018-09-12 |
2020-03-20 |
宜昌人福药业有限责任公司 |
Pharmaceutical composition and preparation method and application thereof
|
JP2019048091A
(en)
|
2018-10-23 |
2019-03-28 |
ニプロ株式会社 |
Prefilled syringe filled with dexmedetomidine injection solution
|
KR102183744B1
(en)
|
2018-11-26 |
2020-11-27 |
연세대학교 산학협력단 |
Methods for pedicting risk of delirium and devices for pedicting risk of delirium using the same
|
CN109620802A
(en)
|
2018-12-05 |
2019-04-16 |
杜皓 |
A kind of anesthesia nasal spray and preparation method thereof
|
CN111481506B
(en)
|
2019-01-25 |
2023-01-24 |
江苏恒瑞医药股份有限公司 |
Pharmaceutical product comprising a nasally administrable dexmedetomidine composition
|
US10900762B2
(en)
|
2019-02-21 |
2021-01-26 |
Aob Products Company |
Ammunition press and components thereof
|
CN112107544A
(en)
|
2019-06-28 |
2020-12-22 |
四川普锐特药业有限公司 |
Dexmedetomidine nasal spray, preparation method and application thereof
|
CN112138250B
(en)
|
2019-06-28 |
2023-04-14 |
四川普锐特药业有限公司 |
Medicament fluid dispenser and dexmedetomidine nasal spray device for maintaining uniform administration
|
CN114375191A
(en)
|
2019-07-19 |
2022-04-19 |
比奥克斯塞尔医疗股份有限公司 |
Non-sedating dexmedetomidine treatment regimen
|
MX2022003224A
(en)
|
2019-09-18 |
2022-06-29 |
Bioxcel Therapeutics Inc |
Systems and methods for detection and prevention of emergence of agitation.
|
IL295489A
(en)
|
2020-02-14 |
2022-10-01 |
Bioxcel Therapeutics Inc |
Systems and methods for detection and prevention of emergence of agitation
|
CN116615243A
(en)
|
2020-10-08 |
2023-08-18 |
比奥克斯塞尔医疗股份有限公司 |
Treatment of bipolar disorder and psychosis using dexmedetomidine hydrochloride
|
TW202241416A
(en)
|
2021-01-04 |
2022-11-01 |
美商百歐克斯賽爾治療公司 |
Dexmedetomidine treatment regimens
|
EP4297871A1
(en)
|
2021-02-26 |
2024-01-03 |
BioXcel Therapeutics, Inc. |
Methods and compositions for treating agitation
|